Impact on health-related quality of life and costs of managing chronic neuropathic pain in academic pain centres: Results from a one-year prospective observational Canadian study

Pain Research and Management

Volumn 20, Issue 6, 2015, Pages 327-333

  Tarride, J E ^a,b   Moulin, D E ^c   Lynch, M ^d   Clark, A J ^d   Stitt, L ^e   Gordon, A ^f   Morley Forster, P K ^c   Nathan, H ^g   Smyth, C ^g   Toth, C ^h   Ware, M A ⁱ  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e LW Stitt Statistical Services   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

^h FRASER HEALTH AUTHORITY   (Canada)

ⁱ MCGILL UNIVERSITY   (Canada)

Author keywords

Chronic neuropathic pain; Economic evaluation; Health related quality of life; Pain management strategy

Indexed keywords

ADULT; ARTICLE; ASYMMETRIC POLYNEUROPATHY; BRIEF PAIN INVENTORY; CANADIAN; CHRONIC NEUROPATHIC PAIN; CHRONIC PAIN; COHORT ANALYSIS; COMPARATIVE STUDY; COST CONTROL; DISEASE DURATION; DOULEUR NEUROPATHIQUE 4 QUESTIONNAIRE; ECONOMIC EVALUATION; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONONEUROPATHY; MULTICENTER STUDY; NEUROPATHIC PAIN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PAIN DISABILITY INDEX; PAIN INTENSITY; POLYNEUROPATHY; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SYMMETRICAL POLYNEUROPATHY; AGED; ANALGESIA; CANADA; DISABILITY; ECONOMICS; MIDDLE AGED; NEURALGIA; NONPARAMETRIC TEST; PAIN MEASUREMENT; PATIENT SATISFACTION; PROCEDURES; PSYCHOLOGY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CANADA; COHORT STUDIES; DISABILITY EVALUATION; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; NEURALGIA; PAIN MANAGEMENT; PAIN MEASUREMENT; PATIENT SATISFACTION; QUALITY OF LIFE; STATISTICS, NONPARAMETRIC; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84958985915     PISSN: 12036765     EISSN: None     Source Type: Journal    
DOI: 10.1155/2015/214873     Document Type: Article

References (31)

1. Andrew R, Derry S, Taylor RS, Straube S, Phillips CJ. The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain. Pain Pract 2014;14:79-94.
2. Langley PC, Van LC, Cappelleri JC, Carroll D. The burden associated with neuropathic pain in Western Europe. J Med Econ 2013;16:85-95.
3. Lachaine J, Gordon A, Choiniere M, Collet JP, Dion D, Tarride JE. Painful neuropathic disorders: An analysis of the Regie de l'Assurance Maladie du Quebec database. Pain Res Manag 2007;12:31-7.
4. Choiniere M, Dion D, Peng P, et al. The Canadian STOP-PAIN project-Part 1: Who are the patients on the waitlists of multidisciplinary pain treatment facilities? Can J Anaesth 2010;57:539-48.
5. Peng P, Choiniere M, Dion D, et al. Challenges in accessing multidisciplinary pain treatment facilities in Canada. Can J Anaesth 2007;54:977-84.
6. Moulin D, Clark A, Gordon A, et al. Canadian multi-centre cohort study to determine the long-term outcomes of the management of chronic neuropathic pain. Pain Res Manag 2013;18:97-101.
7. Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630-5.
8. Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005;114:29-36.
9. Canadian Agency for Drugs and Technologies in Health. Guidelines for the Economic Evaluation of Health Technologies: Canada, 3rd edn. Ottawa: 2006.
10. Turk DC, Dworkin RH, Allen RR, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 2003;106:337-45.
11. Cleeland CS, Ryan KM. Pain assessment: Global use of the brief pain inventory. Ann Acad Med Singapore 1994;23:129-38.
12. Chibnall JT, Tait RC. The pain disability index: Factor structure and normative data. Arch Phys Med Rehabil 1994;75:1082-6.
13. Soer R, Reneman MF, Vroomen PC, Stegeman P, Coppes MH. Responsiveness and minimal clinically important change of the Pain Disability Index in patients with chronic back pain. Spine (Phila Pa 1976) 2012;37:711-5.
14. Melzack R. The short-form McGill Pain Questionnaire. Pain 1987;30:191-7.
15. Ware J, Kosinski M, Dewey J. How to score version two of the SF-36 health survey. Lincoln (RI): QualityMetric Inc; 2000.
16. Drummond M, O'Brien B, Stoddart G, et al. The EuroQol EQ-5D. Methods for the Economic Evaluation of Health Care Programmes. Toronto: Oxford University Press; 1997.
17. U.S. valuation of the EuroQol EQ-5D health states. Rockville (MD): Agency for Healtcare Research and Quality; 2012.
18. Brazier J, Roberts J, Tsuchiya A, Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 2004;13:873-84.
19. Moulin D, Boulanger A, Clark AJ, et al. Pharmacological management of chronic neuropathic pain: Revised consensus statement from the Canadian Pain Society. Pain Res Manag 2014;19:328-35.
20. Sullivan M, Bishop S, Pivik J. The pain catastrophizing scale: Development and validation. Psychological Assessment 1995;7:524-32.
21. Dworkin RH, Turk DC, McDermott MP, et al. Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain 2009;146:238-44.
22. Ridyard CH, Hughes DA. Development of a database of instruments for resource-use measurement: Purpose, feasibility, and design. Value Health 2012;15:650-5.
23. Tarride JE, Blackhouse G, De RG, et al. Cost-effectiveness analysis of elective endovascular repair compared with open surgical repair of abdominal aortic aneurysms for patients at a high surgical risk: A 1-year patient-level analysis conducted in Ontario, Canada. J Vasc Surg 2008;48:779-87.
24. Tarride J, Collet J, Choiniere M, Rousseau C, Gordon A. The economic burdenof neuropathic pain in Canada. J Med Econ 2006;9:55-68.
25. Ministry of Health and Long-Term Care. Schedule of benefits for physician services under the Health Insurance Act. Toronto: Ministry of Health and Long-Term Care; 2013.
26. Ministry of Health and Long-Term Care. Ontario Health Insurance (OHIP) schedule of benefits and fees. Schedule of benefits for laboratory services. Toronto: Ministry of Health and Long-Term Care; 2013.
27. Ministry of Health and Long-Term Care. Ontario Drug Benefit Formulary/Comparative Drug Index. Toronto: Ministry of Health and Long-Term Care; 2015.
28. Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2008;9:105-21.
29. Manning WG, Mullahy J. Estimating log models: To transform or not to transform? J Health Econ 2001;20:461-94.
30. Moran JL, Solomon PJ, Peisach AR, Martin J. New models for old questions: Generalized linear models for cost prediction. J Eval Clin Pract 2007;13:381-9.
31. Statistics Canada. Access to Health Care Services and Waiting Times. Ottawa: Statistics Canada; 2013.